Garre's sclerosing osteomyelitis caused by salmonella group D in a patient with systemic lupus erythematosus: an unusual complication.
We report the case of a 35-year-old male, who was diagnosed with systemic lupus erythematosus (SLE) in 2010 based on the presence of articular, serous, renal, immune, and hematologic involvement. He also had secondary antiphospholipid syndrome (APS). He was treated with prednisone 10 mg per day, hydroxychloroquine 200 mg per day, methotrexate 12.5 mg per week, leflunomide 20 mg per day, and oral anticoagulation previous to the present event. He presented to emergency room with a 7 day disease duration characterized by pain in the left thigh, which increased with physical activity, resulting in claudication; he also had malaise and fever. The X-ray films showed periostitis of the lower half of the left femur with bone marrow narrowing; the scintigraphy showed marked increased uptake in the middle and distal thirds of the left femur, and magnetic resonance imaging (MRI) showed thickening and hyperintensity of the cortex of the diaphysis and distal epiphysis of the femur and endosteal irregularity. Empirical treatment was started with vancomycin for 3 weeks. Femur biopsy and cultures were performed, isolating Salmonella spp. group "D" Vi (-); treatment with cotrimoxazole and ceftazidime for 4 weeks followed by doxycycline and cotrimoxazole for 4 months were given with a favorable functional outcome. This is an unusual case of a young adult with Garre's sclerosing osteomyelitis associated to SLE and caused by salmonella. The literature is reviewed and the clinical conditions predisposing to this infection are discussed, particularly in patients with SLE.
Rheumatology Department, Hospital "Guillermo Almenara Irigoyen" EsSalud, Av. Grau 800. La Victoria, 13, Lima, Peru. claudiaelerafitz@gmail.com.
Claudia
C
Elera-Fitzcarrald
Rheumatology Department, Hospital "Guillermo Almenara Irigoyen" EsSalud, Av. Grau 800. La Victoria, 13, Lima, Peru.
José L
JL
Alfaro-Lozano
Rheumatology Department, Hospital "Guillermo Almenara Irigoyen" EsSalud, Av. Grau 800. La Victoria, 13, Lima, Peru.
César A
CA
Pastor-Asurza
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000188:drug therapy*; D002442:Ceftazidime / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D005269:Femur / Q000473:pathology*; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007555:Isoxazoles / Q000009:adverse effects; D000077339:Leflunomide; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D010019:Osteomyelitis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D011241:Prednisone / Q000009:adverse effects; D012480:Salmonella Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D012598:Sclerosis; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D006886:Hydroxychloroquine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D002442:Ceftazidime; D000077339:Leflunomide; D004318:Doxycycline; D011241:Prednisone; D008727:Methotrexate
Osteomyelitis; Salmonella infections; Systemic lupus erythematosus